Xconomy

SEPTEMBER 30, 2016

Who will be first to market with a new type of cancer treatment known as CAR-T? Who will break free of the pack of companies developing drugs meant to prevent migraines? —Sarepta inked a research pact with Catabasis Pharmaceuticals (NASDAQ: CATB ) to develop a combination therapy for Duchenne.

Avalon 40

Avalon Thousand Oaks Study Startup 40

socalTECH

APRIL 29, 2014

Our first project was 3D imaging of the heart, so that doctors could study a pacemaker and defibrillator recall from the Alfred E. The concept of the incubator is we''re raising a fund here locally and ten percent is local the other 90 percent on AngelList, and we''ll be locating here in the town of Thousand Oaks.

Startup 262

Startup Competition Software Review UCLA 262

Xconomy

JUNE 10, 2016

—More developments arrived this week in the Sarepta Therapeutics (NASDAQ: SRPT ) saga. —On the positive side, Thousand Oaks, CA-based Amgen (NASDAQ: AMGN ) released an overview of Phase 2 data that showed its migraine prevention drug, erenumab, is keeping pace with rival drugs in a heated race to market.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

SoCal Delicious

APRIL 5, 2010

Developers say the ambitious Rice Depot Mercado project will be a mixed-use hub, drawing pedestrian residential traffic from the densely populated area around it. Smith name might ring the loudest bell today for the developer’s various philanthropic efforts. Smith Professorship in Land Use Studies, and the Martin V.

Santa Barbara 53

Santa Barbara Thousand Oaks Oracle Ventura 53